Single-cell derived tumor organoids display diversity in HLA class I peptide presentation

Tumor heterogeneity is a major cause of therapeutic resistance. Immunotherapy may exploit alternative vulnerabilities of drug-resistant cells, where tumor-specific human leukocyte antigen (HLA) peptide ligands are promising leads to invoke targeted anti-tumor responses. Here, we investigate the vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Demmers, Laura C., Kretzschmar, Kai, Van Hoeck, Arne, Bar-Epraïm, Yotam E., van den Toorn, Henk W. P., Koomen, Mandy, van Son, Gijs, van Gorp, Joost, Pronk, Apollo, Smakman, Niels, Cuppen, Edwin, Clevers, Hans, Heck, Albert J. R., Wu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577990/
https://www.ncbi.nlm.nih.gov/pubmed/33087703
http://dx.doi.org/10.1038/s41467-020-19142-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577990/
https://www.ncbi.nlm.nih.gov/pubmed/33087703
http://dx.doi.org/10.1038/s41467-020-19142-9

Ejemplares similares